EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma

The EuroQol-5 Dimension (EQ-5D), developed in 1990, is a most widely used generic tool to measure the health-related quality of life (HRQoL) and considered suitable for patients with asthma. In 2009, the EuroQol Group developed a new EQ-5D version to overcome limitations related to its consistently...

Descripción completa

Detalles Bibliográficos
Autores: Hernandez, Gimena|||0000-0001-5319-3465, Garin, Olatz|||0000-0001-6193-0779, Dima, Alexandra Lelia|||0000-0002-3106-2242, Pont, Angels|||0000-0002-0602-552X, Martí Pastor, Marc|||0000-0001-6189-2178, Alonso, Jordi|||0000-0001-8627-9636, Van Ganse, Eric|||0000-0002-7463-9187, Laforest, Laurent|||0000-0002-3694-7699, de Bruin, Marijn|||0000-0003-3100-6803, Mayoral, K.|||0000-0002-7904-4422, Serra Sutton, Vicky|||0000-0002-7852-175X, Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:226324
Acceso en línea:https://ddd.uab.cat/record/226324
https://dx.doi.org/urn:doi:10.2196/10178
Access Level:acceso abierto
Palabra clave:Asthma
EQ-5D-5L
EuroQol
Health-related quality of life
Web-based survey
Validity
Patient-reported outcome measures
Descripción
Sumario:The EuroQol-5 Dimension (EQ-5D), developed in 1990, is a most widely used generic tool to measure the health-related quality of life (HRQoL) and considered suitable for patients with asthma. In 2009, the EuroQol Group developed a new EQ-5D version to overcome limitations related to its consistently reported high ceiling effect. To enhance the sensitivity for assessing the HRQoL in further patient populations, the number of responses of EQ-5D was increased from 3 to 5 levels (EQ-5D-5L). Moreover, the availability of well-defined requirements for its Web-based administration allows EQ-5D-5L use to monitor the HRQoL in electronic health (eHealth) programs. No study has evaluated the metric properties of the new EQ-5D-5L in patients with asthma yet. This study aims to examine the distribution, construct validity, and reliability of the new EQ-5D-5L questionnaire administered online to adults with asthma. We evaluated patients with asthma (age: 18-40 years) from a primary care setting in France and England, who self-completed the EQ-5D-5L questionnaire online. The inclusion criteria were persistent asthma defined as.

Similares en LA Referencia